Skip to content
Screener

Pulse Biosciences, Inc. PLSE Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Abbott logo
AbbottABT
$1.13B+4.7%
AtriCure logo
AtriCureATRC
7%+0.1pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
$86.38M-1.5%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$13.09M+342%
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
$4.09M-10.7%
LivaNova logo
LivaNovaLIVN
$56.71M+11.9%

Other financials

Income statement

See full
Revenue$434.0K
Gross profit$161.0K
Operating income-$25.3M-24.6%
Net income-$24.7M-28.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$101.6M-4.4%
Total debt$6.8M-17.9%
Total equity$99.5M-4.8%
Total assets$115.6M-3.9%

Cash flow

See full
Operating cash flow-$18.7M-46.1%
CapEx$90.0K-12.6%
Free cash flow-$18.8M-45.6%

Valuation

See full
Market cap$2.96B+196%
Enterprise value$2.87B+217%
P/S2,498.4×

Profitability

See full
Gross margin-0.1%
Operating margin-7,007.8%
Net margin-6,755.8%
FCF margin-5,180.4%

Returns & leverage

See full
Return on equity-78.5%-15.3pp
Debt / equity0.1×0.0×
Current ratio9.6×-2.4×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437749-26-026288
Line itemJune 30, 2026December 31, 2025
Property and equipment, net1,0631,051
Intangible assets, net222575
Goodwill2,7912,791
Right-of-use assets5,3856,010
Other assets403691
Total assets$115,564$94,539
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:

Document

FAQ

What is Pulse Biosciences, Inc.'s operating lease ROU assets?
Pulse Biosciences, Inc. (PLSE) reported operating lease ROU assets of $5.39M in Q2 2026.
How has Pulse Biosciences, Inc.'s operating lease ROU assets changed year-over-year?
Pulse Biosciences, Inc.'s operating lease ROU assets decreased by 14.7% year-over-year, from $6.32M to $5.39M.
What is the long-term trend for Pulse Biosciences, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s operating lease ROU assets has grown at a 3495.6% compound annual growth rate (CAGR), from $0.1 to $6.01M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Pulse Biosciences, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude